兴齐眼药(300573) - 2024年12月6日兴齐眼药投资者关系活动记录表

Group 1: Company Overview - Shenyang Xingqi Eye Pharmaceutical Co., Ltd. is recognized for its high-quality party organization leading to high-quality corporate development, receiving honors such as "Liaoning Province Advanced Grassroots Party Organization" [2] - The company has established a comprehensive ophthalmic drug product system, covering ten categories and producing various forms including gels, eye drops, and ointments [3] Group 2: Product and Technology - The company holds 59 approved ophthalmic drug numbers, with 37 products included in the medical insurance directory and 6 in the national essential drug list [3] - The R&D center has seven technology platforms and various functional departments covering all stages of ophthalmic drug development, recognized as a high-tech enterprise [3] Group 3: Research and Development - The R&D team consists of professionals from top universities, with over 83% holding degrees in pharmacy-related fields and nearly 46% holding master's or doctoral degrees [3] - The company has been designated as a national enterprise technology center and has established a national postdoctoral research station [3] Group 4: Recent Developments - The company’s "China Pharmaceutical Packaging Eye Preparation Research Center" was approved on June 17, 2024, aimed at promoting innovation and technological progress in the pharmaceutical packaging industry [3]